GLP-1 Medication Litigation Resource Center — Last Updated October 2026

Ozempic Lawsuits

Independent Legal Research & Lawsuit Information

Free Confidential Case Evaluation — Check If You Qualify Now

Active GLP-1 Medication Lawsuits

Thousands of patients nationwide have filed lawsuits against Novo Nordisk and Eli Lilly after suffering serious injuries from GLP-1 receptor agonist medications including Ozempic, Wegovy, Mounjaro, Zepbound, and Rybelsus. The multidistrict litigation (MDL 3094) consolidates federal cases in the Eastern District of Pennsylvania.

MDL 3094 Federal Litigation
50 States Filing Options
No Upfront Cost Contingency Basis

Lawsuit Overview & Updates

Do I Qualify for a Lawsuit?

Settlement Amounts & Compensation

Side Effects With Legal Implications

How to File & What You Need

FDA Warnings & Drug Safety News

Lawsuits By State

About This Resource

OzempicLawsuits.net is an independent legal research resource. Our Legal Research Team tracks GLP-1 receptor agonist litigation developments, FDA safety communications, and published court filings to provide accurate, up-to-date information for individuals who may have been harmed by these medications. This site is not a law firm and does not provide legal advice.